Startup based in the United States, most recent round Acquired, 1 tracked investor.
Dice Therapeutics is a company headquartered in the United States. Dice Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Dice Therapeutics is a clinical-stage biotechnology company developing medicines in immunology (and oncology). The company went public in 2021 as NASDAQ:DICE and was later acquired by Eli Lilly for $2.4B.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.